Return to Publications
October 2016
RWJBarnabas HealthRutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including clinical trials and novel therapeutics such as precision medicine and immunotherapy.

Rutgers Cancer Institute of New Jersey Expands Reach to Greater Newark Region

A new partnership between Rutgers Cancer Institute of New Jersey and University Hospital in Newark is resulting in the expansion of National Cancer Institute-designated Comprehensive Cancer Center services to northern New Jersey. Rutgers Cancer Institute of New Jersey at University Hospital will feature expanded oncology services to augment existing radiation oncology services. It will also include access to clinical trials, some only available at NCI-designated Cancer Centers, as well as expanded outreach and education regarding cancer prevention and early detection. State, local, and university dignitaries were on hand at the Newark facility to celebrate the launch of the partnership last month.

breast cancer ribbon

Taking Aim at Triple-Negative Breast Cancer

Precision medicine oncology researchers at Rutgers Cancer Institute aim to validate a new genomic sequencing approach that may help identify a subset of triple-negative breast cancers. At focus are powerful drivers of cancer growth known as 'fusion genes' that are often missed by standard sequencing approaches. Rutgers Cancer Institute Associate Director for Translational Science Shridar Ganesan, MD, PhD, associate professor of medicine and pharmacology at Rutgers Robert Wood Johnson Medical School, will be leading the project that is supported by a grant from the Val Skinner Foundation.

Top Docs

Rutgers Cancer Institute Physicians Named Among 'Tops' in State

More than a dozen physicians at Rutgers Cancer Institute of New Jersey have been named as a 'Top Doctor' by Inside Jersey magazine. Based on peer nominations, board certification, clinical skills, training, years in practice, achievements and other attributes are assessed by a physician-directed research team. Rutgers Cancer Institute physicians on this year's list are also faculty members at Rutgers Robert Wood Johnson Medical School.


Examining the Role of Dairy in Ovarian Cancer Risk in African-American Women

Research from Rutgers Cancer Institute of New Jersey and other institutions shows a diet high in calcium and low in lactose may reduce the risk of ovarian cancer in African-American women. Rutgers Cancer Institute researcher Bo "Bonnie" Qin, PhD, and Elisa Bandera, MD, PhD, who is co-leader of the Cancer Prevention and Control Program at Rutgers Cancer Institute and professor of medicine at Rutgers Robert Wood Johnson Medical School and a professor of epidemiology at Rutgers School of Public Health, also found that sun exposure in the summer months may reduce this risk as well.

Parikh and Byun

Surgery or Radiation Associated with Improved Overall Survival in Advanced Prostate Cancer

A database study examining surgical removal of the prostate gland or a form of radiation therapy known as IMRT to treat prostate cancer that has spread to other parts of the body shows an association between each of these treatments and improved overall survival. John Byun, MD, a resident physician in the Department of Radiation Oncology at Rutgers Robert Wood Johnson Medical School, and Rutgers Cancer Institute radiation oncologist and assistant professor of radiation oncology at Rutgers Robert Wood Johnson Medical School Rahul Parikh, MD, presented study results at the recent American Society for Radiation Oncology Annual Meeting.